Tygacil (tigecycline): Label Change - Increased Mortality Risk

September 1, 2010 by RecallAware · Leave a Comment
Filed under: Medicine 

Healthcare professionals should consider alternatives to Tygacil in patients with severe infections.

Source:Full Article

Huber Needles: Recall - Risk of Coring

August 26, 2010 by RecallAware · Leave a Comment
Filed under: Medicine 

Risk of infection, damage or death of tissue, swelling, or other serious adverse health consequences occurring as a result of the core travelling through blood vessels into the patient’s lungs.

Source:Full Article

Fingerstick Devices to Obtain Blood Specimens: Initial Communication - Risk of Transmitting Bloodborne Pathogens

August 26, 2010 by RecallAware · Leave a Comment
Filed under: Medicine 

Increase in reports of bloodborne infection transmission resulting from the shared use of fingerstick and point-of-care blood testing devices.

Source:Full Article

TimeOut Capsules: Undeclared Drug Ingredient

August 25, 2010 by RecallAware · Leave a Comment
Filed under: Medicine 

Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil, a chemical similar to sildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

Source:Full Article

Octagam [Immune Globulin Intravenous (human)] 5% Liquid Preparation: Market Withdrawal - Risk of Thromboembolic Events

August 25, 2010 by RecallAware · Leave a Comment
Filed under: Medicine 

Customers asked to immediately quarantine the use of affected lots due to the potential for serious thromboembolic events.

Source:Full Article

Octagam [Immune Globulin Intravenous (human)] 5% Liquid Preparation: Recall - Risk of Thromboembolic Events

August 25, 2010 by RecallAware · Leave a Comment
Filed under: Medicine 

Customers asked to immediately quarantine the use of affected lots due to the potential for serious thromboembolic events.

Source:Full Article

Mr. Magic Male Enhancer: Undeclared Drug Ingredient

August 24, 2010 by RecallAware · Leave a Comment
Filed under: Medicine 

Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil and sulfoaildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

Source:Full Article

INOMAX DS Drug-Delivery System: Class I Recall - Risk of Interruption of Drug Flow

August 23, 2010 by RecallAware · Leave a Comment
Filed under: Medicine 

Potential for failure of a pressure switch, which may have an impact on the administration of INOMAX for inhalation to patients.

Source:Full Article

Stalevo(carbidopa/levodopa and entacapone): Ongoing Safety Review: Possible increased cardiovascular risk

August 20, 2010 by RecallAware · Leave a Comment
Filed under: Medicine 

FDA evaluating clinical trial data that suggest patients taking drug may be at an increased risk for cardiovascular events
compared to those taking carbidopa/levodopa

Source:Full Article

Midodrine hydrochloride: FDA Proposes Withdrawal of Low Blood Pressure Drug

August 16, 2010 by RecallAware · Leave a Comment
Filed under: Medicine 

Companies failed to provide evidence of clinical benefit of midodrine hydrochloride because required post-approval studies that verify the clinical benefit of the drug have not been done.

Source:Full Article

Next Page »

References and links to other sites are provided as a courtesy. The recall and safety information provided here is based entirely on manufacturers' and regulatory agencies' press release or other public information. We make no other representations about the accuracy or timeliness of this information